Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 44 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2004Vitamin D metabolism in human osteoblastsAtkins, G.; Anderson, P.; Welldon, K.; Zannettino, A.; Morris, H.; Findlay, D.; Annual Meeting of the American Society for Bone and Mineral Research (26th : 2004 : Seattle, Washington)
2006Vitamin K analogues promote the differentiation of human osteoblasts.Welldon, K.; Atkins, G.; Vincent, C.; Findlay, D.; Annual Meeting of the American Society for Bone and Mineral Research (28th : 2006: Philadelphia, Pennsylvania)
2004NM_013269 Homo sapiens C-type lectin domain family 2, member D (CLEC2D), transcript variant 1, mRNAHu, Y.; Atkins, G.; Zhou, H.; Myers, D.; Quinn, J.; Ly, C.; Gange, C.; Kartsogiannis, V.; Elliott, J.; Kostakis, P.; Zannettino, A.; Cromer, B.; McKinstry, W.; Findlay, D.; Gillespie, M.; Ng, K.
2003The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblasts.Anderson, P.; Atkins, G.; Morris, H.; Kostakis, P.; Findlay, D.; Zannettino, A.; European Symposium on Calcified Tissues (30th : 2003 : Rome, Italy)
2002Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosisEvdokiou, A.; Bouralexis, S.; Atkins, G.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2001Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosisAtkins, G.; Evdokiou, A.; Bouralexis, S.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2003The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblastsAtkins, G.; Anderson, P.; Morris, H.; Zannettino, A.; Kostakis, P.; Findlay, D.; Annual Meeting of the American Society for Bone and Mineral Research (25th : 2003 : Minnesota, USA )
2004Target genes: bone proteinsAtkins, G.; Findlay, D.; Anderson, P.; Morris, H.; Feldman, D.; Pike, J.; Glorieux, F.
2003Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapyBouralexis, S.; Findlay, D.; Atkins, G.; Labrinidis, A.; Hay, S.; Evdokiou, A.
2009Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin responseAtkins, G.; Welldon, K.; Halbout, P.; Findlay, D.